Bone and soft tissue response from a phase I/II study with ODM-201 in metastatic castration-resistant prostate cancer (mCRPC).
暂无分享,去创建一个
V. Kataja | N. James | Jorge A. Garcia | K. Fizazi | C. Massard | A. Protheroe | R. Jones | M. Mustonen | J. Aspegrén | L. Mattila